Hernández-Losa J - Search Results

1

Effect of low doses of actinomycin D on neuroblastoma cell lines.

Cortes CL, Veiga SR, Almacellas E, Hernández-Losa J, Ferreres JC, Kozma SC, Ambrosio S, Thomas G, Tauler A. Cortes CL, et al. Mol Cancer. 2016 Jan 4;15:1. doi: 10.1186/s12943-015-0489-8. Mol Cancer. 2016. PMID: 26728659 Free PMC article.

2

Primary renal epithelioid dedifferentiated liposarcoma mimicking a GLI1-amplified neoplasm.

Machado I, Abaunz AJ, Claramunt R, Silva TM, Romagosa C, Sesé M, Hernandez-Losa J, López-Guerrero JA, Llombart-Bosch A. Machado I, et al. Among authors: hernandez losa j. Pathol Res Pract. 2024 May;257:155279. doi: 10.1016/j.prp.2024.155279. Epub 2024 Apr 2. Pathol Res Pract. 2024. PMID: 38608370 No abstract available.

3

The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.

López-Fauqued M, Gil R, Grueso J, Hernandez-Losa J, Pujol A, Moliné T, Recio JA. López-Fauqued M, et al. Int J Cancer. 2010 Apr 1;126(7):1549-61. doi: 10.1002/ijc.24926. Int J Cancer. 2010. PMID: 19810100 Free article.

4

Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer.

Bielanska J, Hernández-Losa J, Pérez-Verdaguer M, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A. Bielanska J, et al. Curr Cancer Drug Targets. 2009 Dec;9(8):904-14. doi: 10.2174/156800909790192400. Curr Cancer Drug Targets. 2009. PMID: 20025600

5

Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.

Andreu-Pérez P, Hernandez-Losa J, Moliné T, Gil R, Grueso J, Pujol A, Cortés J, Avila MA, Recio JA. Andreu-Pérez P, et al. BMC Cancer. 2010 Jun 8;10:265. doi: 10.1186/1471-2407-10-265. BMC Cancer. 2010. PMID: 20529342 Free PMC article.

6

Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A. Bielanska J, et al. Cell Physiol Biochem. 2010;26(2):219-26. doi: 10.1159/000320528. Epub 2010 Aug 24. Cell Physiol Biochem. 2010. PMID: 20798505 Free article.

7

Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.

Felipe A, Bielanska J, Comes N, Vallejo A, Roig S, Ramón Y Cajal S, Condom E, Hernández-Losa J, Ferreres JC. Felipe A, et al. Curr Med Chem. 2012;19(5):661-74. doi: 10.2174/092986712798992048. Curr Med Chem. 2012. PMID: 22204339 Review.

8

Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón y Cajal S, Condom E, Ferreres JC, Felipe A. Bielanska J, et al. Cancer Invest. 2012 Mar;30(3):203-8. doi: 10.3109/07357907.2012.654872. Cancer Invest. 2012. PMID: 22360360

9

Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials.

Dienstmann R, Serpico D, Rodon J, Saura C, Macarulla T, Elez E, Alsina M, Capdevila J, Perez-Garcia J, Sánchez-Ollé G, Aura C, Prudkin L, Landolfi S, Hernández-Losa J, Vivancos A, Tabernero J. Dienstmann R, et al. Mol Cancer Ther. 2012 Sep;11(9):2062-71. doi: 10.1158/1535-7163.MCT-12-0290. Epub 2012 Jun 21. Mol Cancer Ther. 2012. PMID: 22723336

10

Increased voltage-dependent K⁺ channel Kv1.3 and Kv1.5 expression correlates with leiomyosarcoma aggressiveness.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A. Bielanska J, et al. Oncol Lett. 2012 Aug;4(2):227-230. doi: 10.3892/ol.2012.718. Epub 2012 May 16. Oncol Lett. 2012. PMID: 22844358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page